Delivery Order SPE2DB20D2001-SPE2DB23FM43Z
Award Date
3/7/23
Potential Completion Date
3/8/23
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FJ6A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,525.27 firm-fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used for the treatment of malaria, lupus, and certain types of arthritis. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,909.44 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used to treat certain types of malaria, lupus, and arthritis. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,726.73, is for the delivery of Plaquenil 200 mg tablets, a medication used to treat certain medical conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,818.48 firm-fixed-price delivery order is for the supply of 4,560,862,411 units of Plaquenil 200 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $6,052.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Plaquenil 200 mg tablets in 100-count bottles. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $9,222.36, is a delivery order for Plaquenil 200 mg tablets (100 count). The award did not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This...
This federal contract award is a delivery order (SPE2DB20D2104|SPE2DB25FMJKJ) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,899.37, is for the supply of Plaquenil 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,026.35, is for the delivery of Plaquenil 200 mg tablets over the period ending November 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...